Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma
Clinical trial NCT00673010 · COMPLETED
Trial details
- NCT number
- NCT00673010
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-03-07
- Primary completion
- 2025-10-02
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.